{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:33:43Z","timestamp":1790714023733,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,31]]},"DOI":"10.7759\/cureus.44493","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:46:11Z","timestamp":1693529171000},"source":"Crossref","is-referenced-by-count":46,"title":["Role of Metformin in Polycystic Ovary Syndrome (PCOS): Related Infertility"],"prefix":"10.7759","author":[{"given":"Ghalia M","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May M","family":"Almouteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah T","family":"Alnakhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis E","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al.. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999, 84:4006-4011. 10.1210\/jcem.84.11.6148","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/569862","article-title":"Phenotype and metabolic disorders in polycystic ovary syndrome","volume":"2012","author":"G\u0142uszak O","year":"2012","unstructured":"G\u0142uszak O, Stopi\u0144ska-G\u0142uszak U, Glinicki P, et al.. Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol. 2012, 2012:569862. 10.5402\/2012\/569862","journal-title":"ISRN Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-47. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref4","article-title":"Insulin resistance: the clinical spectrum","volume":"6","author":"Mantzoros CS","year":"1995","unstructured":"Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. Adv Endocrinol Metab. 1995, 6:193-232.","journal-title":"Adv Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112886","article-title":"Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp","volume":"79","author":"Bergman RN","year":"1987","unstructured":"Bergman RN, Prager R, Volund A, et al.. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987, 79:790-800. 10.1172\/JCI112886","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro RS","year":"2004","unstructured":"Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004, 59:141-154. 10.1097\/01.OGX.0000109523.25076.E2","journal-title":"Obstet Gynecol Surv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.97789","article-title":"A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome","volume":"5","author":"Roy KK","year":"2012","unstructured":"Roy KK, Baruah J, Singla S, et al.. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci. 2012, 5:20-25. 10.4103\/0974-1208.97789","journal-title":"J Hum Reprod Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1395838","article-title":"Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial","volume":"34","author":"Rezk M","year":"2018","unstructured":"Rezk M, Shaheen AE, Saif El-Nasr I. Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial. Gynecol Endocrinol. 2018, 34:298-300. 10.1080\/09513590.2017.1395838","journal-title":"Gynecol Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.06.063","article-title":"A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate-resistant polycystic ovary syndrome","volume":"132","author":"El-khayat W","year":"2016","unstructured":"El-khayat W, Abdel Moety G, Al Mohammady M, et al.. A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate-resistant polycystic ovary syndrome. Int J Gynaecol Obstet. 2016, 132:206-209. 10.1016\/j.ijgo.2015.06.063","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler JE","year":"2008","unstructured":"Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008, 358:47-54.","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord JM","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003, 327:951-953. 10.1136\/bmj.327.7421.951","journal-title":"BMJ"},{"key":"ref12","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"4","author":"Roe AH","year":"2011","unstructured":"Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011, 4:45-51.","journal-title":"Rev Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70286-3","article-title":"Polycystic ovary syndrome","volume":"26","author":"Goudas VT","year":"1997","unstructured":"Goudas VT, Dumesic DA. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1997, 26:893-912. 10.1016\/S0889-8529(05)70286-3","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref14","article-title":"Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females","volume":"1","author":"Guraya SS","year":"2019","unstructured":"Guraya SS. Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females. J Microsc Ultrastruct. 2019, 1:0-34.","journal-title":"J Microsc Ultrastruct"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.06.003","article-title":"Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome","volume":"107","author":"Tamimi W","year":"2009","unstructured":"Tamimi W, Siddiqui IA, Tamim H, et al.. Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome. Int J Gynaecol Obstet. 2009, 107:54-57. 10.1016\/j.ijgo.2009.06.003","journal-title":"Int J Gynaecol Obstet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva D","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, et al.. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016, 106:6-15. 10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield RL","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016, 37:467-520. 10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson VL","year":"1999","unstructured":"Nelson VL, Legro RS, Strauss JF 3rd, et al.. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 1999, 13:946-957. 10.1210\/mend.13.6.0311","journal-title":"Mol Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.61","article-title":"Polycystic ovary syndrome in adolescents","volume":"32","author":"Franks S","year":"2008","unstructured":"Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008, 32:1035-1041. 10.1038\/ijo.2008.61","journal-title":"Int J Obes (Lond)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1371092","article-title":"Childhood obesity and its impact on the development of adolescent PCOS","volume":"32","author":"Anderson AD","year":"2014","unstructured":"Anderson AD, Solorzano CM, McCartney CR. Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med. 2014, 32:202-213. 10.1055\/s-0034-1371092","journal-title":"Semin Reprod Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/12.suppl_1.53","article-title":"Insulin regulation of human ovarian androgens","volume":"12","author":"Nestler JE","year":"1997","unstructured":"Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997, 12:53-62. 10.1093\/humrep\/12.suppl_1.53","journal-title":"Hum Reprod"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.1.5393","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro RS","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, et al.. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999, 84:165-169. 10.1210\/jcem.84.1.5393","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas J","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, et al.. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014, 2014:1-17. 10.1155\/2014\/719050","journal-title":"Int J Reprod Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.1.6293","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti P","year":"2000","unstructured":"Moghetti P, Castello R, Negri C, et al.. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000, 85:139-146. 10.1210\/jcem.85.1.6293","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)55675-1","article-title":"Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin","volume":"59","author":"Bergh C","year":"1993","unstructured":"Bergh C, Carlsson B, Olsson JH, et al.. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril. 1993, 59:323-331. 10.1016\/s0015-0282(16)55675-1","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81:19-25. 10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz R","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al.. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016, 2:16057. 10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mefs.2010.10.002","article-title":"Polycystic ovary syndrome and impact on health","volume":"16","author":"Allahbadia GN","year":"2011","unstructured":"Allahbadia GN, Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil Soc J. 2011, 16:19-37. 10.1016\/j.mefs.2010.10.002","journal-title":"Middle East Fertil Soc J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2005.00623.x","article-title":"Development of polycystic ovary syndrome: involvement of genetic and environmental factors","volume":"29","author":"Franks S","year":"2006","unstructured":"Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006, 29:278-285; discussion 286-290. 10.1111\/j.1365-2605.2005.00623.x","journal-title":"Int J Androl"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470717","article-title":"The genetic basis of polycystic ovary syndrome","volume":"147","author":"Xita N","year":"2002","unstructured":"Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol. 2002, 147:717-725. 10.1530\/eje.0.1470717","journal-title":"Eur J Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz BO","year":"2008","unstructured":"Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2008, 93:162-8. 10.1210\/jc.2007-1834","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh109","article-title":"Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy","volume":"19","author":"Glueck CJ","year":"2004","unstructured":"Glueck CJ, Goldenberg N, Wang P, et al.. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004, 19:510-521. 10.1093\/humrep\/deh109","journal-title":"Hum Reprod"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834c0010","article-title":"The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c","volume":"21","author":"Christensen MM","year":"2011","unstructured":"Christensen MM, Brasch-Andersen C, Green H, et al.. The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c. Pharmacogenet Genomics. 2011, 21:837-850. 10.1097\/FPC.0b013e32834c0010","journal-title":"Pharmacogenet Genomics"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12328","article-title":"New mechanisms of metformin action: Focusing on mitochondria and the gut","volume":"6","author":"Hur KY","year":"2015","unstructured":"Hur KY, Lee MS. New mechanisms of metformin action: Focusing on mitochondria and the gut. J Diabetes Investig. 2015, 6:600-609. 10.1111\/jdi.12328","journal-title":"J Diabetes Investig"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s1262-3636(03)72785-2","article-title":"Reducing insulin resistance with metformin: the evidence today","volume":"29","author":"Giannarelli R","year":"2003","unstructured":"Giannarelli R, Aragona M, Coppelli A, et al.. Reducing insulin resistance with metformin: the evidence today. Diabetes Metab. 2003, 29:6S28-6S35. 10.1016\/s1262-3636(03)72785-2","journal-title":"Diabetes Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh440","article-title":"Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome","volume":"19","author":"Kashyap S","year":"2004","unstructured":"Kashyap S, Wells GA, Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod. 2004, 19:2474-2483. 10.1093\/humrep\/deh440","journal-title":"Hum Reprod"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"11","author":"Lord JM","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochr Datab Syst Rev. 2003, 11:CD003053. 10.1002\/14651858.CD003053","journal-title":"Cochr Datab Syst Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming R","year":"2002","unstructured":"Fleming R, Hopkinson ZE, Wallace AM, et al.. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab. 2002, 87:569-574. 10.1210\/jcem.87.2.8261","journal-title":"J Clin Endocrinol Metab"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub3","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang T","year":"2009","unstructured":"Tang T, Lord JM, Norman RJ, et al.. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochr Datab Syst Rev. 2009, CD003053. 10.1002\/14651858.CD003053.pub3","journal-title":"Cochr Datab Syst Rev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang T","year":"2006","unstructured":"Tang T, Glanville J, Hayden CJ, et al.. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod. 2006, 21:80-89. 10.1093\/humrep\/dei311","journal-title":"Hum Reprod"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial","volume":"332","author":"Moll E","year":"2006","unstructured":"Moll E, Bossuyt PM, Korevaar JC, et al.. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ. 2006, 332:1485. 10.1136\/bmj.38867.631551.55","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro RS","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD, et al.. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007, 356:551-566. 10.1056\/NEJMoa063971","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen AH","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, et al.. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016, 22:687-708. 10.1093\/humupd\/dmw025","journal-title":"Hum Reprod Update"},{"key":"ref44","article-title":"Oral hypoglycaemics in the first trimester and fetal outcome","volume":"65","author":"Coetzee EJ","year":"1984","unstructured":"Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J. 1984, 65:635-637.","journal-title":"S Afr Med J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz DJ","year":"2002","unstructured":"Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al.. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002, 87:524-529. 10.1210\/jcem.87.2.8207","journal-title":"J Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne LR","year":"2005","unstructured":"Harborne LR, Sattar N, Norman JE, et al.. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005, 90:4593-4598. 10.1210\/jc.2004-2283","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/167371-role-of-metformin-in-polycystic-ovary-syndrome-pcos-related-infertility","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:57:32Z","timestamp":1707490652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/167371-role-of-metformin-in-polycystic-ovary-syndrome-pcos-related-infertility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.44493","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}